Jerome Wilson Joins PRA International's Late Phase Ser...( Dr. Jerome Wilson to ser...)

Dr. Jerome Wilson to serve as Lead Epidemiologist

RALEIGH, N.C., Oct. 27 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announced today the appointment of Dr. Jerome Wilson as Senior Medical Director of Late Phase Services. As the Lead Epidemiologist, Dr. Wilson is responsible for providing consulting services and developing post-marketing strategies for PRA clients.

PRA provides extensive Phase IV Post-Marketing services to pharmaceutical and biotech companies. The company has executed more than 150 Late Phase studies in 23 countries, recruiting over 126,000 patients in nearly 12,000 sites.

In addition to more than 15 years of scientific management experience in the pharmaceutical industry, Dr. Wilson served as Senior Interdisciplinary Scientist and Team Leader for Anthrax Therapeutics at the U.S. Department of Health and Human Services (HHS). For this role, the Biomedical Advanced Research and Development Authority Office recognized Dr. Wilson for distinguished service.

Dr. Wilson also served as Associate Director for Scientific Program Operations at the National Center on Minority Health and Health Disparities at the National Institutes of Health (NIH). He received the NIH Director's Award for his work on the Genome Wide Association Studies Policy Development Team.

Additionally, Dr. Wilson served as Senior Director/Team Leader of Outcomes Research at Pfizer and has held appointments at the Memorial Sloan-Kettering Cancer Center, the National Cancer Institute's Division of Cancer Epidemiology and Genetics, Howard University's Cancer Center, and Georgetown University's School of Medicine.

"We are pleased to add Dr. Wilson to our Late Phase Services team," commented Maria Harrison, Vice President of PRA Late Phase Services. "His expertise in the post-marketing field will serve as a tremendous benefit to our clients, and our team."

Dr. Wilson holds an A.B. Cum Laude from Di
'/>"/>